Chad Hamilton to Bevacizumab
This is a "connection" page, showing publications Chad Hamilton has written about Bevacizumab.
Connection Strength
0.108
-
Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer. Gynecol Oncol. 2008 Dec; 111(3):530-2.
Score: 0.073
-
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 06; 149(3):525-530.
Score: 0.036